176 related articles for article (PubMed ID: 7225602)
1. Therapeutic strategies in multiple myeloma.
Durie BG; Salmon S
Bull Cancer; 1980; 67(4):450-7. PubMed ID: 7225602
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: a therapeutic enigma.
Hoogstraten B
Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
Rajkumar SV; Buadi F
Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
[TBL] [Abstract][Full Text] [Related]
4. [Multiple myeloma].
Peest D
Ther Umsch; 1996 Feb; 53(2):147-51. PubMed ID: 8629265
[TBL] [Abstract][Full Text] [Related]
5. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
6. [Interferon therapy in multiple myeloma].
Micksche M
Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366
[TBL] [Abstract][Full Text] [Related]
7. [Multiple myeloma. Role of prognostic factors and staging in a therapeutic program].
Bolis S; Bregani ER; Rossini F; Casaroli I; Lanzi E; Maffè P; Baldicchi L; Borin L; Mingozzi S; Tripputi P
Recenti Prog Med; 1994 Jan; 85(1):49-55. PubMed ID: 8184181
[TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
[TBL] [Abstract][Full Text] [Related]
9. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Atanackovic D; Luetkens T; Hildebrandt Y; Arfsten J; Bartels K; Horn C; Stahl T; Cao Y; Zander AR; Bokemeyer C; Kröger N
Clin Cancer Res; 2009 Feb; 15(4):1343-52. PubMed ID: 19190130
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses.
Haas PS; Denz U; Ihorst G; Engelhardt M
Eur J Haematol; 2008 Apr; 80(4):303-9. PubMed ID: 18182082
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in multiple myeloma: selection using Cox's proportional hazard model.
Pasqualetti P; Collacciani A; Maccarone C; Casale R
Biomed Pharmacother; 1996; 50(1):29-35. PubMed ID: 8672729
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma index: verification of a new prognostic approach with evaluation of treatment response.
Bettini R; Tonolini M; Bernasconi M
Haematologica; 1998 Aug; 83(8):708-13. PubMed ID: 9793254
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of multiple myeloma].
Brouet JC
Rev Prat; 1993 Feb; 43(3):321-5. PubMed ID: 8502963
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma.
Hungria VT; Maiolino A; Martinez G; Colleoni GW; Coelho EO; Rocha L; Nunes R; Bittencourt R; Oliveira LC; Faria RM; Pasquini R; Magalhães SM; Souza CA; Pinto Neto JV; Barreto L; Andrade E; Portella Mdo S; Bolejack V; Durie BG;
Haematologica; 2008 May; 93(5):791-2. PubMed ID: 18450738
[No Abstract] [Full Text] [Related]
16. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and staging systems of multiple myeloma:
Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
[TBL] [Abstract][Full Text] [Related]
18. Cellular kinetics in multiple myeloma. A new approach to staging and treatment.
Salmon SE; Durie BG
Arch Intern Med; 1975 Jan; 135(1):131-8. PubMed ID: 1089396
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
20. Evaluation of five staging systems in 470 patients with multiple myeloma.
Mihou D; Katodritou I; Zervas K
Haematologica; 2006 Aug; 91(8):1149-50. PubMed ID: 16885059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
